REFERENCES
- American Psychiatric Association Task Force. Treatment of Psychiatric Disorders. American Psychiatric Association Press, Washington, DC 1989; 187
- Gilman A. G., Goodman L. S., Rawl T. W., et al. The Pharmacologic Basis of Therapeutics. Macmillan, New York 1985
- Griffiths R. R., Sannerud V. D. Abuse of dependence on benzodiazepines and other anxiolytic/sedative drugs. Psychopharmacology the Third Generation of Progress, H. Y. Melzer. Raven, New York 1987; 1535–1541
- Anton R. F., Becker H. C. Pharmacology and pathophysiology of alcohol withdrawal. Handbook of Experimental Pharmacology, the Pharmacology of Alcohol Abuse, H. R. Kranzler. Spring-Verlag, Berlin 1995; 114: 315–367
- Butler D., Messiha F. S. Alcohol withdrawal and carbamazepine. Alcohol 1986; 3: 113–129
- Schweizer E., Rickels K., Case W. G., et al. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Arch. Gen. Psychiatry 1991; 48: 448–452
- Malcolm R., Ballenger J. C., Sturgis E. T., et al. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am. J. Psychiatry 1989; 146: 617–621
- Bowden C. L., Brugger A. M., Swann A. C. Efficacy of divalproex versus lithium and placebo in the treatment of mania. JAMA 1994; 271: 918–924
- Rimmer E. M., Richens A. An update on sodium valproate. Pharmacotherapy 1985; 5: 171–184
- Trimble M. R., Thompson P. J. Sodium valproate and cognitive function. Epilepsia 1986; 25(suppl. 1)S60–S64
- Sullivan J. T., Swift R. M., Lewis D. C. Benzodiazepine requirements during alcohol withdrawal syndrome: clinical implications of using standardized withdrawal scale. J. Clin. Psychopharmacol. 1991; 11: 291–295